Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why ShockWave Medical Shares Are Tanking Today


Though ShockWave Medical (NASDAQ: SWAV) shared upbeat news with investors Tuesday, shares of the medical device company fell as much as 13% in afternoon trading. The stock was down about 10% as of 3:20 p.m. EDT. 

Two news items appear to be impacting the share price. 

First, Shockwave, which focuses on treating calcified plaque, announced it had received a Breakthrough Device Designation from the Food and Drug Administration for its C2 Coronary IVL Catheter. The device uses sonic waves to fracture calcium deposits in the heart with the goal of improving blood flow. The C2 is already available for sale in Europe, and Shockwave is currently enrolling patients in a pivotal study to hopefully win  U.S. regulatory approval. Gaining that Breakthrough Device Designation from the FDA certainly is a good sign that it eventually will be approved. 

Continue reading


Source Fool.com

Like: 0
Share

Comments